Novel motif:34: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:40, 9 September 2013
name: | motif34_GANCCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010624 | regulation of Schwann cell proliferation | 4.687878e-14 |
GO:0060251 | regulation of glial cell proliferation | 1.031219e-12 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.772459e-11 |
GO:0002019 | regulation of renal output by angiotensin | 1.328053e-10 |
GO:0002002 | regulation of angiotensin levels in blood | 6.294237e-10 |
GO:0060020 | Bergmann glial cell differentiation | 2.746715e-9 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 4.478233e-9 |
GO:0070208 | protein heterotrimerization | 5.391754e-9 |
GO:0031440 | regulation of mRNA 3'-end processing | 6.621242e-9 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 9.886428e-9 |
GO:0008210 | estrogen metabolic process | 1.351774e-8 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.613222e-8 |
GO:0032753 | positive regulation of interleukin-4 production | 3.297390e-8 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 4.369866e-8 |
GO:0007386 | compartment pattern specification | 4.443614e-8 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 6.746011e-8 |
GO:0071874 | cellular response to norepinephrine stimulus | 8.817637e-8 |
GO:0060253 | negative regulation of glial cell proliferation | 9.580009e-8 |
GO:0016056 | rhodopsin mediated signaling pathway | 1.164353e-7 |
GO:0007296 | vitellogenesis | 1.539460e-7 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.765977e-7 |
GO:0060897 | neural plate regionalization | 2.361346e-7 |
GO:0046434 | organophosphate catabolic process | 3.958287e-7 |
GO:0051693 | actin filament capping | 4.016429e-7 |
GO:0007522 | visceral muscle development | 4.283529e-7 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 5.181932e-7 |
GO:0048570 | notochord morphogenesis | 6.328018e-7 |
GO:0060252 | positive regulation of glial cell proliferation | 6.402329e-7 |
GO:0032571 | response to vitamin K | 6.923444e-7 |
GO:0006012 | galactose metabolic process | 7.050499e-7 |
GO:0006689 | ganglioside catabolic process | 7.242092e-7 |
GO:0030509 | BMP signaling pathway | 7.531929e-7 |
GO:0034504 | protein localization to nucleus | 8.136142e-7 |
GO:0008078 | mesodermal cell migration | 1.029346e-6 |
GO:0021999 | neural plate anterior/posterior regionalization | 1.076551e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.114007e-6 |
GO:0030037 | actin filament reorganization involved in cell cycle | 1.350217e-6 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.435471e-6 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 1.675602e-6 |
GO:0032933 | SREBP-mediated signaling pathway | 1.715169e-6 |
GO:0035814 | negative regulation of renal sodium excretion | 1.787256e-6 |
GO:0071276 | cellular response to cadmium ion | 1.789287e-6 |
GO:0051580 | regulation of neurotransmitter uptake | 1.790050e-6 |
GO:0034505 | tooth mineralization | 2.259155e-6 |
GO:0060177 | regulation of angiotensin metabolic process | 2.407763e-6 |
GO:0003180 | aortic valve morphogenesis | 2.485944e-6 |
GO:0000072 | M phase specific microtubule process | 2.562631e-6 |
GO:0009313 | oligosaccharide catabolic process | 2.851884e-6 |
GO:0006545 | glycine biosynthetic process | 2.851884e-6 |
GO:0042396 | phosphagen biosynthetic process | 2.930881e-6 |
GO:0070574 | cadmium ion transmembrane transport | 3.305798e-6 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.548689e-6 |
GO:0007603 | phototransduction, visible light | 3.592523e-6 |
GO:0019532 | oxalate transport | 3.636729e-6 |
GO:0014028 | notochord formation | 3.762193e-6 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 3.783727e-6 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 3.836672e-6 |
GO:0045655 | regulation of monocyte differentiation | 3.993280e-6 |
GO:0060337 | type I interferon-mediated signaling pathway | 4.810508e-6 |
GO:0014807 | regulation of somitogenesis | 5.029560e-6 |
GO:0014014 | negative regulation of gliogenesis | 5.422701e-6 |
GO:0046314 | phosphocreatine biosynthetic process | 5.525175e-6 |
GO:0034340 | response to type I interferon | 5.583187e-6 |
GO:0002579 | positive regulation of antigen processing and presentation | 5.618087e-6 |
GO:0032462 | regulation of protein homooligomerization | 6.024923e-6 |
GO:0060326 | cell chemotaxis | 6.201750e-6 |
GO:0000413 | protein peptidyl-prolyl isomerization | 6.695472e-6 |
GO:0030835 | negative regulation of actin filament depolymerization | 6.762181e-6 |
GO:0045838 | positive regulation of membrane potential | 7.155942e-6 |
GO:0060586 | multicellular organismal iron ion homeostasis | 8.785680e-6 |
GO:0032459 | regulation of protein oligomerization | 8.941301e-6 |
GO:0060323 | head morphogenesis | 9.130951e-6 |
GO:0014013 | regulation of gliogenesis | 1.030929e-5 |
GO:0002268 | follicular dendritic cell differentiation | 1.032475e-5 |
GO:0043462 | regulation of ATPase activity | 1.079008e-5 |
GO:0045657 | positive regulation of monocyte differentiation | 1.132421e-5 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.146712e-5 |
GO:0046724 | oxalic acid secretion | 1.146712e-5 |
GO:0045604 | regulation of epidermal cell differentiation | 1.152134e-5 |
GO:0042177 | negative regulation of protein catabolic process | 1.157231e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.162767e-5 |
GO:0060319 | primitive erythrocyte differentiation | 1.186734e-5 |
GO:0002575 | basophil chemotaxis | 1.186734e-5 |
GO:0043491 | protein kinase B signaling cascade | 1.221350e-5 |
GO:0014015 | positive regulation of gliogenesis | 1.266209e-5 |
GO:0001694 | histamine biosynthetic process | 1.294990e-5 |
GO:0045575 | basophil activation | 1.294990e-5 |
GO:0003416 | endochondral bone growth | 1.342691e-5 |
GO:0007602 | phototransduction | 1.388220e-5 |
GO:0032526 | response to retinoic acid | 1.481400e-5 |
GO:0002407 | dendritic cell chemotaxis | 1.483568e-5 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 1.504922e-5 |
GO:0009651 | response to salt stress | 1.631992e-5 |
GO:0071421 | manganese ion transmembrane transport | 1.790818e-5 |
GO:0071104 | response to interleukin-9 | 1.807228e-5 |
GO:0045619 | regulation of lymphocyte differentiation | 1.865976e-5 |
GO:0060896 | neural plate pattern specification | 2.112925e-5 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 2.311285e-5 |
GO:0060291 | long-term synaptic potentiation | 2.364362e-5 |
GO:0015884 | folic acid transport | 2.434224e-5 |
GO:0070979 | protein K11-linked ubiquitination | 2.488200e-5 |
GO:0010626 | negative regulation of Schwann cell proliferation | 2.492346e-5 |
GO:0001823 | mesonephros development | 2.515400e-5 |
GO:0001569 | patterning of blood vessels | 2.543923e-5 |
GO:0045835 | negative regulation of meiosis | 2.604146e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.694596e-5 |
GO:0016188 | synaptic vesicle maturation | 2.717733e-5 |
GO:0045618 | positive regulation of keratinocyte differentiation | 2.727278e-5 |
GO:0045061 | thymic T cell selection | 2.741635e-5 |
GO:0046855 | inositol phosphate dephosphorylation | 2.755532e-5 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 2.850655e-5 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 2.850655e-5 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 2.850655e-5 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 2.850655e-5 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 2.896112e-5 |
GO:0035305 | negative regulation of dephosphorylation | 3.083214e-5 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 3.094939e-5 |
GO:0016142 | O-glycoside catabolic process | 3.190477e-5 |
GO:0006438 | valyl-tRNA aminoacylation | 3.241325e-5 |
GO:0031077 | post-embryonic camera-type eye development | 3.342543e-5 |
GO:0030903 | notochord development | 3.459943e-5 |
GO:0060346 | bone trabecula formation | 3.471441e-5 |
GO:0045668 | negative regulation of osteoblast differentiation | 3.473617e-5 |
GO:0010529 | negative regulation of transposition | 3.634596e-5 |
GO:0051016 | barbed-end actin filament capping | 3.891396e-5 |
GO:0035308 | negative regulation of protein dephosphorylation | 4.305470e-5 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 4.305470e-5 |
GO:0006544 | glycine metabolic process | 4.322133e-5 |
GO:0045060 | negative thymic T cell selection | 4.439465e-5 |
GO:0002026 | regulation of the force of heart contraction | 4.473106e-5 |
GO:0030834 | regulation of actin filament depolymerization | 4.495120e-5 |
GO:0060325 | face morphogenesis | 4.549466e-5 |
GO:0006695 | cholesterol biosynthetic process | 4.569763e-5 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 4.675830e-5 |
GO:0051365 | cellular response to potassium ion starvation | 4.793476e-5 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 4.975594e-5 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 5.042500e-5 |
GO:0032863 | activation of Rac GTPase activity | 5.171137e-5 |
GO:0097150 | neuronal stem cell maintenance | 5.171137e-5 |
GO:0046847 | filopodium assembly | 5.219018e-5 |
GO:0042274 | ribosomal small subunit biogenesis | 5.268684e-5 |
GO:0007028 | cytoplasm organization | 5.304525e-5 |
GO:0051291 | protein heterooligomerization | 5.311983e-5 |
GO:0071545 | inositol phosphate catabolic process | 5.413221e-5 |
GO:0014896 | muscle hypertrophy | 5.442123e-5 |
GO:0006703 | estrogen biosynthetic process | 5.576976e-5 |
GO:0018894 | dibenzo-p-dioxin metabolic process | 5.576976e-5 |
GO:0009062 | fatty acid catabolic process | 5.613100e-5 |
GO:0045580 | regulation of T cell differentiation | 6.003279e-5 |
GO:0048242 | epinephrine secretion | 6.127432e-5 |
GO:0060456 | positive regulation of digestive system process | 6.384096e-5 |
GO:0032792 | negative regulation of CREB transcription factor activity | 6.580015e-5 |
GO:0001300 | chronological cell aging | 6.832017e-5 |
GO:0006690 | icosanoid metabolic process | 6.936347e-5 |
GO:0021773 | striatal medium spiny neuron differentiation | 7.040244e-5 |
GO:0009895 | negative regulation of catabolic process | 7.052751e-5 |
GO:0030322 | stabilization of membrane potential | 7.107178e-5 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 7.107178e-5 |
GO:0060455 | negative regulation of gastric acid secretion | 7.254139e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 7.254139e-5 |
GO:0097118 | neuroligin clustering | 7.330355e-5 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 7.428645e-5 |
GO:0043654 | recognition of apoptotic cell | 7.491732e-5 |
GO:0048569 | post-embryonic organ development | 7.609971e-5 |
GO:0008624 | induction of apoptosis by extracellular signals | 7.664965e-5 |
GO:0030035 | microspike assembly | 7.864172e-5 |
GO:0007263 | nitric oxide mediated signal transduction | 8.020075e-5 |
GO:0070206 | protein trimerization | 8.140003e-5 |
GO:0014895 | smooth muscle hypertrophy | 8.177385e-5 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 8.177385e-5 |
GO:0010243 | response to organic nitrogen | 8.595703e-5 |
GO:0050685 | positive regulation of mRNA processing | 8.845700e-5 |
GO:0006635 | fatty acid beta-oxidation | 8.905728e-5 |
GO:0015862 | uridine transport | 8.948078e-5 |
GO:0009070 | serine family amino acid biosynthetic process | 9.264612e-5 |
GO:0048241 | epinephrine transport | 9.785613e-5 |
GO:0031295 | T cell costimulation | 9.999371e-5 |
GO:0035418 | protein localization to synapse | 1.004774e-4 |
GO:0097116 | gephyrin clustering | 1.023331e-4 |
GO:0034014 | response to triglyceride | 1.023331e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 1.023331e-4 |
GO:0032673 | regulation of interleukin-4 production | 1.033511e-4 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 1.038025e-4 |
GO:0046456 | icosanoid biosynthetic process | 1.051156e-4 |
GO:0002443 | leukocyte mediated immunity | 1.145470e-4 |
GO:0007021 | tubulin complex assembly | 1.162367e-4 |
GO:0018208 | peptidyl-proline modification | 1.172403e-4 |
GO:0002449 | lymphocyte mediated immunity | 1.174279e-4 |
GO:0050975 | sensory perception of touch | 1.198758e-4 |
GO:0002003 | angiotensin maturation | 1.203395e-4 |
GO:0097119 | postsynaptic density protein 95 clustering | 1.204181e-4 |
GO:0097104 | postsynaptic membrane assembly | 1.204181e-4 |
GO:0000076 | DNA replication checkpoint | 1.234658e-4 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.282813e-4 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 1.299238e-4 |
GO:0048844 | artery morphogenesis | 1.317584e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.330665e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 1.377520e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 1.408575e-4 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1.466357e-4 |
GO:0042074 | cell migration involved in gastrulation | 1.487664e-4 |
GO:0002250 | adaptive immune response | 1.518311e-4 |
GO:0016140 | O-glycoside metabolic process | 1.545128e-4 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.549522e-4 |
GO:0044057 | regulation of system process | 1.560231e-4 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 1.599000e-4 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.615170e-4 |
GO:0035026 | leading edge cell differentiation | 1.686916e-4 |
GO:0072668 | tubulin complex biogenesis | 1.721272e-4 |
GO:0030149 | sphingolipid catabolic process | 1.893917e-4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.950160e-4 |
GO:0050863 | regulation of T cell activation | 1.974308e-4 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 1.985884e-4 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 2.041834e-4 |
GO:0044062 | regulation of excretion | 2.090386e-4 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 2.095895e-4 |
GO:0030513 | positive regulation of BMP signaling pathway | 2.142517e-4 |
GO:0051588 | regulation of neurotransmitter transport | 2.160898e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.200945e-4 |
GO:0019221 | cytokine-mediated signaling pathway | 2.210320e-4 |
GO:0002883 | regulation of hypersensitivity | 2.211209e-4 |
GO:0033559 | unsaturated fatty acid metabolic process | 2.226050e-4 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 2.273024e-4 |
GO:0060035 | notochord cell development | 2.338850e-4 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 2.352149e-4 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 2.431357e-4 |
GO:0000088 | mitotic prophase | 2.459313e-4 |
GO:0010171 | body morphogenesis | 2.472151e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.492031e-4 |
GO:0006026 | aminoglycan catabolic process | 2.522276e-4 |
GO:0002274 | myeloid leukocyte activation | 2.536287e-4 |
GO:0001817 | regulation of cytokine production | 2.540576e-4 |
GO:0048711 | positive regulation of astrocyte differentiation | 2.563636e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.581245e-4 |
GO:2000107 | negative regulation of leukocyte apoptosis | 2.587982e-4 |
GO:0006694 | steroid biosynthetic process | 2.657252e-4 |
GO:0009069 | serine family amino acid metabolic process | 2.660264e-4 |
GO:0048536 | spleen development | 2.664609e-4 |
GO:0042755 | eating behavior | 2.717765e-4 |
GO:0060343 | trabecula formation | 2.738179e-4 |
GO:0032862 | activation of Rho GTPase activity | 2.803495e-4 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 2.844962e-4 |
GO:2000001 | regulation of DNA damage checkpoint | 2.902161e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 2.908455e-4 |
GO:0050870 | positive regulation of T cell activation | 2.926128e-4 |
GO:0002920 | regulation of humoral immune response | 2.930937e-4 |
GO:0001974 | blood vessel remodeling | 2.949636e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 3.009873e-4 |
GO:0001941 | postsynaptic membrane organization | 3.013537e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 3.053615e-4 |
GO:0001757 | somite specification | 3.074188e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 3.076878e-4 |
GO:0008065 | establishment of blood-nerve barrier | 3.327352e-4 |
GO:0002765 | immune response-inhibiting signal transduction | 3.327352e-4 |
GO:0032463 | negative regulation of protein homooligomerization | 3.355007e-4 |
GO:0002922 | positive regulation of humoral immune response | 3.363126e-4 |
GO:0072676 | lymphocyte migration | 3.399568e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 3.508765e-4 |
GO:0042886 | amide transport | 3.662063e-4 |
GO:0009583 | detection of light stimulus | 3.689745e-4 |
GO:0002005 | angiotensin catabolic process in blood | 3.765354e-4 |
GO:0070947 | neutrophil mediated killing of fungus | 3.765354e-4 |
GO:0006027 | glycosaminoglycan catabolic process | 3.808195e-4 |
GO:0051496 | positive regulation of stress fiber assembly | 3.826164e-4 |
GO:0051965 | positive regulation of synapse assembly | 3.828918e-4 |
GO:0010701 | positive regulation of norepinephrine secretion | 3.836976e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 3.864302e-4 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 3.882214e-4 |
GO:0046687 | response to chromate | 4.004272e-4 |
GO:0033986 | response to methanol | 4.004272e-4 |
GO:0042415 | norepinephrine metabolic process | 4.065658e-4 |
GO:0060236 | regulation of mitotic spindle organization | 4.128336e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 4.135170e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.159508e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 4.182813e-4 |
GO:0009635 | response to herbicide | 4.287311e-4 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 4.330543e-4 |
GO:0060840 | artery development | 4.374437e-4 |
GO:0072178 | nephric duct morphogenesis | 4.421456e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.494654e-4 |
GO:0061032 | visceral serous pericardium development | 4.494654e-4 |
GO:0014061 | regulation of norepinephrine secretion | 4.632015e-4 |
GO:0001807 | regulation of type IV hypersensitivity | 4.674165e-4 |
GO:0072166 | posterior mesonephric tubule development | 4.777679e-4 |
GO:0045058 | T cell selection | 4.841558e-4 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 4.886427e-4 |
GO:0070383 | DNA cytosine deamination | 4.922686e-4 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 4.922686e-4 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 4.922686e-4 |
GO:0060457 | negative regulation of digestive system process | 4.922686e-4 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 4.977424e-4 |
GO:0008612 | peptidyl-lysine modification to hypusine | 4.977424e-4 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 5.006014e-4 |
GO:0002830 | positive regulation of type 2 immune response | 5.035111e-4 |
GO:0010816 | calcitonin catabolic process | 5.035130e-4 |
GO:0034959 | endothelin maturation | 5.035130e-4 |
GO:0010814 | substance P catabolic process | 5.035130e-4 |
GO:0010508 | positive regulation of autophagy | 5.050966e-4 |
GO:0042339 | keratan sulfate metabolic process | 5.117358e-4 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 5.177487e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 5.177487e-4 |
GO:0070715 | sodium-dependent organic cation transport | 5.201074e-4 |
GO:0060731 | positive regulation of intestinal epithelial structure maintenance | 5.201074e-4 |
GO:0052106 | quorum sensing involved in interaction with host | 5.201074e-4 |
GO:0043383 | negative T cell selection | 5.222144e-4 |
GO:0003073 | regulation of systemic arterial blood pressure | 5.244523e-4 |
GO:0045221 | negative regulation of FasL biosynthetic process | 5.371814e-4 |
GO:0002731 | negative regulation of dendritic cell cytokine production | 5.371814e-4 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 5.414173e-4 |
GO:0031952 | regulation of protein autophosphorylation | 5.750239e-4 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 5.804646e-4 |
GO:0072176 | nephric duct development | 5.997245e-4 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 6.029220e-4 |
GO:0003105 | negative regulation of glomerular filtration | 6.029220e-4 |
GO:0006855 | drug transmembrane transport | 6.333147e-4 |
GO:0001768 | establishment of T cell polarity | 6.513597e-4 |
GO:0051929 | positive regulation of calcium ion transport via voltage-gated calcium channel activity | 6.513597e-4 |
GO:0043647 | inositol phosphate metabolic process | 6.518061e-4 |
GO:0018963 | phthalate metabolic process | 6.547418e-4 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 6.722549e-4 |
GO:0008625 | induction of apoptosis via death domain receptors | 7.000645e-4 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 7.044293e-4 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 7.089205e-4 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 7.114707e-4 |
GO:0048710 | regulation of astrocyte differentiation | 7.131083e-4 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 7.154149e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 7.386388e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 7.497248e-4 |
GO:0001957 | intramembranous ossification | 7.528312e-4 |
GO:0015893 | drug transport | 7.548809e-4 |
GO:0050764 | regulation of phagocytosis | 7.561008e-4 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 7.778737e-4 |
GO:0061383 | trabecula morphogenesis | 7.789538e-4 |
GO:0045342 | MHC class II biosynthetic process | 7.881293e-4 |
GO:0070839 | divalent metal ion export | 7.881293e-4 |
GO:0043091 | L-arginine import | 7.881293e-4 |
GO:0032632 | interleukin-3 production | 7.881293e-4 |
GO:0006876 | cellular cadmium ion homeostasis | 7.881293e-4 |
GO:0015707 | nitrite transport | 7.881293e-4 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 7.881293e-4 |
GO:0046466 | membrane lipid catabolic process | 7.900899e-4 |
GO:0016486 | peptide hormone processing | 8.065801e-4 |
GO:0006196 | AMP catabolic process | 8.079176e-4 |
GO:0019388 | galactose catabolic process | 8.079176e-4 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 8.079176e-4 |
GO:0032615 | interleukin-12 production | 8.203719e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 8.260290e-4 |
GO:0097091 | synaptic vesicle clustering | 8.301824e-4 |
GO:0035854 | eosinophil fate commitment | 8.431759e-4 |
GO:0030222 | eosinophil differentiation | 8.431759e-4 |
GO:0071870 | cellular response to catecholamine stimulus | 8.435141e-4 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 8.641315e-4 |
GO:0019322 | pentose biosynthetic process | 8.670707e-4 |
GO:0010940 | positive regulation of necrotic cell death | 8.684967e-4 |
GO:0003417 | growth plate cartilage development | 8.684967e-4 |
GO:0046655 | folic acid metabolic process | 8.728895e-4 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 8.774317e-4 |
GO:0010954 | positive regulation of protein processing | 9.049051e-4 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 9.049321e-4 |
GO:0022616 | DNA strand elongation | 9.061580e-4 |
GO:0043101 | purine-containing compound salvage | 9.102360e-4 |
GO:0001808 | negative regulation of type IV hypersensitivity | 9.565136e-4 |
GO:0031104 | dendrite regeneration | 9.614687e-4 |
GO:0006607 | NLS-bearing substrate import into nucleus | 9.803916e-4 |
GO:0050821 | protein stabilization | 9.840523e-4 |
GO:0032653 | regulation of interleukin-10 production | 9.923980e-4 |
GO:0045582 | positive regulation of T cell differentiation | 1.008202e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1.026777e-3 |
GO:0021599 | abducens nerve formation | 1.029066e-3 |
GO:0051932 | synaptic transmission, GABAergic | 1.029066e-3 |
GO:0007634 | optokinetic behavior | 1.029066e-3 |
GO:2000210 | positive regulation of anoikis | 1.036638e-3 |
GO:0009132 | nucleoside diphosphate metabolic process | 1.046963e-3 |
GO:0044242 | cellular lipid catabolic process | 1.054767e-3 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.071070e-3 |
GO:0042593 | glucose homeostasis | 1.080993e-3 |
GO:0042088 | T-helper 1 type immune response | 1.102089e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.121289e-3 |
GO:0042117 | monocyte activation | 1.129648e-3 |
GO:0070670 | response to interleukin-4 | 1.132009e-3 |
GO:0000212 | meiotic spindle organization | 1.132967e-3 |
GO:0061017 | hepatoblast differentiation | 1.137508e-3 |
GO:0001692 | histamine metabolic process | 1.139057e-3 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.157042e-3 |
GO:0008617 | guanosine metabolic process | 1.172133e-3 |
GO:0060014 | granulosa cell differentiation | 1.172133e-3 |
GO:0042866 | pyruvate biosynthetic process | 1.172133e-3 |
GO:0070079 | histone H4-R3 demethylation | 1.192548e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.192548e-3 |
GO:0070078 | histone H3-R2 demethylation | 1.192548e-3 |
GO:0051491 | positive regulation of filopodium assembly | 1.197636e-3 |
GO:0010621 | negative regulation of transcription by transcription factor localization | 1.260163e-3 |
GO:0032656 | regulation of interleukin-13 production | 1.295829e-3 |
GO:0009637 | response to blue light | 1.303137e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 1.303137e-3 |
GO:0048705 | skeletal system morphogenesis | 1.308509e-3 |
GO:0019724 | B cell mediated immunity | 1.308678e-3 |
GO:0051926 | negative regulation of calcium ion transport | 1.318502e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.333087e-3 |
GO:0060611 | mammary gland fat development | 1.335148e-3 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 1.353498e-3 |
GO:0048263 | determination of dorsal identity | 1.353646e-3 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 1.353646e-3 |
GO:0035510 | DNA dealkylation | 1.358276e-3 |
GO:0046618 | drug export | 1.359931e-3 |
GO:0006090 | pyruvate metabolic process | 1.360331e-3 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.366502e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.370433e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.370433e-3 |
GO:0060450 | positive regulation of hindgut contraction | 1.376793e-3 |
GO:0045925 | positive regulation of female receptivity | 1.376793e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.376793e-3 |
GO:0019402 | galactitol metabolic process | 1.408081e-3 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.408081e-3 |
GO:0009586 | rhodopsin mediated phototransduction | 1.427187e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 1.431380e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 1.432940e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 1.442539e-3 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.445552e-3 |
GO:0006110 | regulation of glycolysis | 1.465043e-3 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1.466918e-3 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 1.466932e-3 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.492318e-3 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.492318e-3 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1.492318e-3 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.492318e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 1.502448e-3 |
GO:0018879 | biphenyl metabolic process | 1.502448e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 1.510683e-3 |
GO:0014075 | response to amine stimulus | 1.517565e-3 |
GO:0048708 | astrocyte differentiation | 1.593929e-3 |
GO:0007412 | axon target recognition | 1.606335e-3 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 1.613773e-3 |
GO:0019882 | antigen processing and presentation | 1.624059e-3 |
GO:0002027 | regulation of heart rate | 1.629934e-3 |
GO:0006606 | protein import into nucleus | 1.631493e-3 |
GO:0050432 | catecholamine secretion | 1.671978e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.681387e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.694155e-3 |
GO:0002828 | regulation of type 2 immune response | 1.707433e-3 |
GO:0006002 | fructose 6-phosphate metabolic process | 1.752236e-3 |
GO:0043171 | peptide catabolic process | 1.752236e-3 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 1.761793e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 1.789464e-3 |
GO:0045581 | negative regulation of T cell differentiation | 1.790243e-3 |
GO:0032964 | collagen biosynthetic process | 1.826995e-3 |
GO:0051130 | positive regulation of cellular component organization | 1.830847e-3 |
GO:0045338 | farnesyl diphosphate metabolic process | 1.846036e-3 |
GO:0032674 | regulation of interleukin-5 production | 1.862296e-3 |
GO:0003300 | cardiac muscle hypertrophy | 1.869746e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 1.897300e-3 |
GO:0061379 | inferior colliculus development | 1.898211e-3 |
GO:0061381 | cell migration in diencephalon | 1.898211e-3 |
GO:0061374 | mammillothalamic axonal tract development | 1.898211e-3 |
GO:0021855 | hypothalamus cell migration | 1.898211e-3 |
GO:0061011 | hepatic duct development | 1.931523e-3 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 1.948522e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 2.008863e-3 |
GO:0015747 | urate transport | 2.008863e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 2.008863e-3 |
GO:0033273 | response to vitamin | 2.023273e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 2.042179e-3 |
GO:0060644 | mammary gland epithelial cell differentiation | 2.062176e-3 |
GO:0002446 | neutrophil mediated immunity | 2.062925e-3 |
GO:0009584 | detection of visible light | 2.074721e-3 |
GO:0010520 | regulation of reciprocal meiotic recombination | 2.095572e-3 |
GO:0002432 | granuloma formation | 2.095572e-3 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2.106697e-3 |
GO:0000966 | RNA 5'-end processing | 2.106697e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 2.148737e-3 |
GO:0023041 | neuronal signal transduction | 2.149259e-3 |
GO:0048635 | negative regulation of muscle organ development | 2.162261e-3 |
GO:0010544 | negative regulation of platelet activation | 2.174099e-3 |
GO:0080111 | DNA demethylation | 2.188009e-3 |
GO:0032649 | regulation of interferon-gamma production | 2.195024e-3 |
GO:0006754 | ATP biosynthetic process | 2.234459e-3 |
GO:0070669 | response to interleukin-2 | 2.235075e-3 |
GO:0015817 | histidine transport | 2.246846e-3 |
GO:0002522 | leukocyte migration involved in immune response | 2.253131e-3 |
GO:0072179 | nephric duct formation | 2.258697e-3 |
GO:0033504 | floor plate development | 2.260624e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 2.264462e-3 |
GO:0032461 | positive regulation of protein oligomerization | 2.295546e-3 |
GO:0034695 | response to prostaglandin E stimulus | 2.310412e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 2.310412e-3 |
GO:0034635 | glutathione transport | 2.325985e-3 |
GO:0071335 | hair follicle cell proliferation | 2.325985e-3 |
GO:0032290 | peripheral nervous system myelin formation | 2.325985e-3 |
GO:0010189 | vitamin E biosynthetic process | 2.325985e-3 |
GO:0031503 | protein complex localization | 2.326202e-3 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 2.340134e-3 |
GO:0071299 | cellular response to vitamin A | 2.341927e-3 |
GO:0044236 | multicellular organismal metabolic process | 2.350650e-3 |
GO:0006400 | tRNA modification | 2.381397e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 2.456723e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.463023e-3 |
GO:0031064 | negative regulation of histone deacetylation | 2.477919e-3 |
GO:0006525 | arginine metabolic process | 2.483109e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 2.505076e-3 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 2.508444e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000303 | response to superoxide | 9.290672e-9 |
GO:0051764 | actin crosslink formation | 3.097949e-8 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.194238e-7 |
GO:0006705 | mineralocorticoid biosynthetic process | 2.614398e-7 |
GO:0014819 | regulation of skeletal muscle contraction | 2.656377e-7 |
GO:0019430 | removal of superoxide radicals | 4.573696e-7 |
GO:0000305 | response to oxygen radical | 5.256411e-7 |
GO:0051138 | positive regulation of NK T cell differentiation | 6.944598e-7 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 7.863442e-7 |
GO:0030157 | pancreatic juice secretion | 1.462312e-6 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.515834e-6 |
GO:0060427 | lung connective tissue development | 2.109686e-6 |
GO:0000302 | response to reactive oxygen species | 2.390028e-6 |
GO:0045017 | glycerolipid biosynthetic process | 2.433520e-6 |
GO:0046514 | ceramide catabolic process | 2.625682e-6 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.943668e-6 |
GO:0003229 | ventricular cardiac muscle tissue development | 3.040761e-6 |
GO:0030149 | sphingolipid catabolic process | 3.669954e-6 |
GO:0050832 | defense response to fungus | 4.822276e-6 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.468448e-6 |
GO:0042542 | response to hydrogen peroxide | 6.743402e-6 |
GO:0015074 | DNA integration | 7.218472e-6 |
GO:0019731 | antibacterial humoral response | 8.431475e-6 |
GO:0006734 | NADH metabolic process | 8.917280e-6 |
GO:0006188 | IMP biosynthetic process | 1.331601e-5 |
GO:0043534 | blood vessel endothelial cell migration | 1.357402e-5 |
GO:0090076 | relaxation of skeletal muscle | 1.455180e-5 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.455180e-5 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.361946e-5 |
GO:0060442 | branching involved in prostate gland morphogenesis | 2.377613e-5 |
GO:0051013 | microtubule severing | 2.511880e-5 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 2.815625e-5 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 2.815625e-5 |
GO:0006801 | superoxide metabolic process | 2.897100e-5 |
GO:0017157 | regulation of exocytosis | 2.983015e-5 |
GO:0043300 | regulation of leukocyte degranulation | 3.140717e-5 |
GO:0002679 | respiratory burst involved in defense response | 3.427057e-5 |
GO:0048537 | mucosal-associated lymphoid tissue development | 3.714870e-5 |
GO:0002432 | granuloma formation | 4.086707e-5 |
GO:0043313 | regulation of neutrophil degranulation | 4.586723e-5 |
GO:0035967 | cellular response to topologically incorrect protein | 5.047311e-5 |
GO:0034505 | tooth mineralization | 5.065325e-5 |
GO:0043542 | endothelial cell migration | 5.220193e-5 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 5.750038e-5 |
GO:0032855 | positive regulation of Rac GTPase activity | 5.934025e-5 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 6.297021e-5 |
GO:0019730 | antimicrobial humoral response | 6.687528e-5 |
GO:0043154 | negative regulation of caspase activity | 6.753684e-5 |
GO:0006707 | cholesterol catabolic process | 6.760990e-5 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 6.823444e-5 |
GO:0001957 | intramembranous ossification | 7.081325e-5 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 7.441201e-5 |
GO:0045988 | negative regulation of striated muscle contraction | 7.571274e-5 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 7.891618e-5 |
GO:0006650 | glycerophospholipid metabolic process | 8.615653e-5 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 8.712430e-5 |
GO:0034614 | cellular response to reactive oxygen species | 8.921098e-5 |
GO:0046474 | glycerophospholipid biosynthetic process | 9.147343e-5 |
GO:0050432 | catecholamine secretion | 1.134701e-4 |
GO:0045989 | positive regulation of striated muscle contraction | 1.138548e-4 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.157720e-4 |
GO:0034616 | response to laminar fluid shear stress | 1.310117e-4 |
GO:0018195 | peptidyl-arginine modification | 1.375253e-4 |
GO:0045655 | regulation of monocyte differentiation | 1.378689e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.532804e-4 |
GO:0046339 | diacylglycerol metabolic process | 1.579734e-4 |
GO:0072539 | T-helper 17 cell differentiation | 1.613035e-4 |
GO:0097039 | protein linear polyubiquitination | 1.614642e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.614642e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 1.692224e-4 |
GO:0034969 | histone arginine methylation | 1.696672e-4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.737169e-4 |
GO:0019432 | triglyceride biosynthetic process | 1.760906e-4 |
GO:0045933 | positive regulation of muscle contraction | 1.817700e-4 |
GO:0090185 | negative regulation of kidney development | 2.083174e-4 |
GO:0043691 | reverse cholesterol transport | 2.095456e-4 |
GO:0021631 | optic nerve morphogenesis | 2.116587e-4 |
GO:0046340 | diacylglycerol catabolic process | 2.204348e-4 |
GO:0045658 | regulation of neutrophil differentiation | 2.339314e-4 |
GO:0002551 | mast cell chemotaxis | 2.366428e-4 |
GO:0046486 | glycerolipid metabolic process | 2.519849e-4 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.583863e-4 |
GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 2.638051e-4 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 2.669243e-4 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 2.669243e-4 |
GO:0033364 | mast cell secretory granule organization | 2.713529e-4 |
GO:0019882 | antigen processing and presentation | 3.253062e-4 |
GO:0048242 | epinephrine secretion | 3.435091e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 3.536899e-4 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 3.549722e-4 |
GO:0035066 | positive regulation of histone acetylation | 3.594570e-4 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 3.897044e-4 |
GO:0030166 | proteoglycan biosynthetic process | 3.932643e-4 |
GO:0071529 | cementum mineralization | 3.938834e-4 |
GO:0045217 | cell-cell junction maintenance | 3.954850e-4 |
GO:0048535 | lymph node development | 4.024149e-4 |
GO:0046504 | glycerol ether biosynthetic process | 4.108497e-4 |
GO:0060620 | regulation of cholesterol import | 4.305586e-4 |
GO:0045660 | positive regulation of neutrophil differentiation | 4.400074e-4 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 4.483732e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 4.563291e-4 |
GO:0046112 | nucleobase biosynthetic process | 4.768169e-4 |
GO:0035966 | response to topologically incorrect protein | 4.797855e-4 |
GO:0035246 | peptidyl-arginine N-methylation | 4.875654e-4 |
GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 5.044396e-4 |
GO:0046470 | phosphatidylcholine metabolic process | 5.089031e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 5.097094e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 5.118469e-4 |
GO:0032094 | response to food | 5.156851e-4 |
GO:0018216 | peptidyl-arginine methylation | 5.172965e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 5.205820e-4 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 5.234320e-4 |
GO:0001935 | endothelial cell proliferation | 5.469940e-4 |
GO:0046463 | acylglycerol biosynthetic process | 5.480728e-4 |
GO:0050951 | sensory perception of temperature stimulus | 5.518276e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.628559e-4 |
GO:0008654 | phospholipid biosynthetic process | 5.902096e-4 |
GO:0090224 | regulation of spindle organization | 6.146431e-4 |
GO:0045792 | negative regulation of cell size | 6.146431e-4 |
GO:0071218 | cellular response to misfolded protein | 6.194799e-4 |
GO:0000072 | M phase specific microtubule process | 6.194799e-4 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 6.234502e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 6.490997e-4 |
GO:0048241 | epinephrine transport | 6.544846e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 6.611528e-4 |
GO:0045730 | respiratory burst | 6.659767e-4 |
GO:0009113 | purine base biosynthetic process | 6.775551e-4 |
GO:0031943 | regulation of glucocorticoid metabolic process | 7.028881e-4 |
GO:0070301 | cellular response to hydrogen peroxide | 7.218098e-4 |
GO:0070845 | polyubiquitinated misfolded protein transport | 7.253359e-4 |
GO:0031914 | negative regulation of synaptic plasticity | 7.253359e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 7.255543e-4 |
GO:0042439 | ethanolamine-containing compound metabolic process | 7.325789e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 7.420751e-4 |
GO:0006839 | mitochondrial transport | 7.624018e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 7.885868e-4 |
GO:0006102 | isocitrate metabolic process | 7.885868e-4 |
GO:0006986 | response to unfolded protein | 8.111442e-4 |
GO:0045948 | positive regulation of translational initiation | 8.627582e-4 |
GO:0090075 | relaxation of muscle | 8.839878e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 9.115595e-4 |
GO:0070508 | cholesterol import | 9.172581e-4 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 9.222059e-4 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 9.241193e-4 |
GO:0002885 | positive regulation of hypersensitivity | 9.256206e-4 |
GO:0051693 | actin filament capping | 9.360395e-4 |
GO:0042311 | vasodilation | 9.438980e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.470384e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 9.773762e-4 |
GO:0007109 | cytokinesis, completion of separation | 9.986074e-4 |
GO:0007596 | blood coagulation | 1.010684e-3 |
GO:0006937 | regulation of muscle contraction | 1.045310e-3 |
GO:0006164 | purine nucleotide biosynthetic process | 1.048004e-3 |
GO:0044243 | multicellular organismal catabolic process | 1.049095e-3 |
GO:0006110 | regulation of glycolysis | 1.050320e-3 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.052934e-3 |
GO:0031167 | rRNA methylation | 1.128763e-3 |
GO:0009408 | response to heat | 1.156862e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.164155e-3 |
GO:0009266 | response to temperature stimulus | 1.194789e-3 |
GO:0031642 | negative regulation of myelination | 1.209238e-3 |
GO:0021562 | vestibulocochlear nerve development | 1.221404e-3 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.229022e-3 |
GO:0033037 | polysaccharide localization | 1.229022e-3 |
GO:0042268 | regulation of cytolysis | 1.240082e-3 |
GO:0000387 | spliceosomal snRNP assembly | 1.240082e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 1.252012e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.256938e-3 |
GO:0060299 | negative regulation of sarcomere organization | 1.256938e-3 |
GO:0051977 | lysophospholipid transport | 1.256938e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 1.256938e-3 |
GO:0033002 | muscle cell proliferation | 1.268242e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 1.295700e-3 |
GO:0090207 | regulation of triglyceride metabolic process | 1.297864e-3 |
GO:0035023 | regulation of Rho protein signal transduction | 1.297974e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.307302e-3 |
GO:0072593 | reactive oxygen species metabolic process | 1.367876e-3 |
GO:0035094 | response to nicotine | 1.393535e-3 |
GO:0019233 | sensory perception of pain | 1.401139e-3 |
GO:0006984 | ER-nucleus signaling pathway | 1.442202e-3 |
GO:0070831 | basement membrane assembly | 1.460873e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 1.473752e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 1.477366e-3 |
GO:0034227 | tRNA thio-modification | 1.493256e-3 |
GO:0006927 | transformed cell apoptosis | 1.512152e-3 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.516474e-3 |
GO:0006084 | acetyl-CoA metabolic process | 1.574369e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 1.618660e-3 |
GO:0030101 | natural killer cell activation | 1.625550e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.650600e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 1.693175e-3 |
GO:0006883 | cellular sodium ion homeostasis | 1.706678e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 1.726936e-3 |
GO:0045861 | negative regulation of proteolysis | 1.732066e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.735741e-3 |
GO:0007586 | digestion | 1.743343e-3 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 1.767199e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.770992e-3 |
GO:0001887 | selenium compound metabolic process | 1.770992e-3 |
GO:0007599 | hemostasis | 1.850076e-3 |
GO:0031946 | regulation of glucocorticoid biosynthetic process | 1.857130e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.909770e-3 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.985708e-3 |
GO:0043301 | negative regulation of leukocyte degranulation | 2.004699e-3 |
GO:0050878 | regulation of body fluid levels | 2.012764e-3 |
GO:0019637 | organophosphate metabolic process | 2.023452e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 2.086251e-3 |
GO:0071827 | plasma lipoprotein particle organization | 2.092826e-3 |
GO:0030837 | negative regulation of actin filament polymerization | 2.103132e-3 |
GO:0001886 | endothelial cell morphogenesis | 2.122208e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.155074e-3 |
GO:0043491 | protein kinase B signaling cascade | 2.199147e-3 |
GO:0060707 | trophoblast giant cell differentiation | 2.236109e-3 |
GO:0032506 | cytokinetic process | 2.273676e-3 |
GO:0055017 | cardiac muscle tissue growth | 2.298733e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 2.309076e-3 |
GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 2.321063e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 2.326063e-3 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 2.326063e-3 |
GO:0019532 | oxalate transport | 2.370467e-3 |
GO:0006958 | complement activation, classical pathway | 2.427862e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 2.445184e-3 |
GO:0002051 | osteoblast fate commitment | 2.445184e-3 |
GO:0070243 | regulation of thymocyte apoptosis | 2.461777e-3 |
GO:0051541 | elastin metabolic process | 2.503582e-3 |
GO:0060621 | negative regulation of cholesterol import | 2.503582e-3 |
GO:0002475 | antigen processing and presentation via MHC class Ib | 2.503582e-3 |
GO:0046847 | filopodium assembly | 2.514357e-3 |
GO:0032963 | collagen metabolic process | 2.514820e-3 |
GO:0006099 | tricarboxylic acid cycle | 2.544914e-3 |
GO:0006144 | purine base metabolic process | 2.586898e-3 |
GO:0035907 | dorsal aorta development | 2.660939e-3 |
GO:0051241 | negative regulation of multicellular organismal process | 2.741487e-3 |
GO:0006942 | regulation of striated muscle contraction | 2.773524e-3 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 2.810363e-3 |
GO:0046356 | acetyl-CoA catabolic process | 2.852043e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.858766e-3 |
GO:0071299 | cellular response to vitamin A | 2.873002e-3 |
GO:0072267 | metanephric capsule specification | 2.896787e-3 |
GO:2000657 | negative regulation of apolipoprotein binding | 2.896787e-3 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 2.896787e-3 |
GO:0006409 | tRNA export from nucleus | 2.896787e-3 |
GO:0006756 | AMP phosphorylation | 2.913885e-3 |
GO:0032863 | activation of Rac GTPase activity | 2.924925e-3 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 2.924925e-3 |
GO:0009190 | cyclic nucleotide biosynthetic process | 2.938900e-3 |
GO:0030046 | parallel actin filament bundle assembly | 2.945496e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 2.951598e-3 |
GO:0006407 | rRNA export from nucleus | 2.995448e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 2.995448e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 3.025544e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 3.029113e-3 |
GO:0001710 | mesodermal cell fate commitment | 3.062347e-3 |
GO:0060997 | dendritic spine morphogenesis | 3.079174e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 3.084508e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3.111111e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 3.129486e-3 |
GO:0048541 | Peyer's patch development | 3.130179e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 3.137482e-3 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 3.144776e-3 |
GO:0070328 | triglyceride homeostasis | 3.186967e-3 |
GO:0030174 | regulation of DNA-dependent DNA replication initiation | 3.259494e-3 |
GO:0009165 | nucleotide biosynthetic process | 3.282453e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 3.325277e-3 |
GO:0031670 | cellular response to nutrient | 3.332000e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 3.352206e-3 |
GO:0009117 | nucleotide metabolic process | 3.368738e-3 |
GO:0060346 | bone trabecula formation | 3.442175e-3 |
GO:0071300 | cellular response to retinoic acid | 3.487290e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 3.520498e-3 |
GO:0010830 | regulation of myotube differentiation | 3.547698e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 3.553972e-3 |
GO:0051029 | rRNA transport | 3.581132e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 3.623859e-3 |
GO:0048144 | fibroblast proliferation | 3.623859e-3 |
GO:0030574 | collagen catabolic process | 3.655028e-3 |
GO:0060419 | heart growth | 3.711165e-3 |
GO:0032796 | uropod organization | 3.743088e-3 |
GO:0072522 | purine-containing compound biosynthetic process | 3.747904e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 3.797296e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 3.858939e-3 |
GO:0006171 | cAMP biosynthetic process | 3.858939e-3 |
GO:0060193 | positive regulation of lipase activity | 3.872572e-3 |
GO:0031645 | negative regulation of neurological system process | 3.926063e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 3.940181e-3 |
GO:0072668 | tubulin complex biogenesis | 3.976153e-3 |
GO:0016048 | detection of temperature stimulus | 4.000366e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 4.000366e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 4.189800e-3 |
GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein | 4.190218e-3 |
GO:0003065 | positive regulation of heart rate by epinephrine | 4.190218e-3 |
GO:0035813 | regulation of renal sodium excretion | 4.218651e-3 |
GO:0019674 | NAD metabolic process | 4.240903e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 4.242092e-3 |
GO:0072003 | kidney rudiment formation | 4.242092e-3 |
GO:0042732 | D-xylose metabolic process | 4.242092e-3 |
GO:0048389 | intermediate mesoderm development | 4.242092e-3 |
GO:0000060 | protein import into nucleus, translocation | 4.246731e-3 |
GO:0030502 | negative regulation of bone mineralization | 4.272501e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 4.403022e-3 |
GO:0035912 | dorsal aorta morphogenesis | 4.403022e-3 |
GO:0030038 | contractile actin filament bundle assembly | 4.403022e-3 |
GO:0051187 | cofactor catabolic process | 4.416343e-3 |
GO:0031638 | zymogen activation | 4.530551e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 4.681469e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 4.681469e-3 |
GO:0006626 | protein targeting to mitochondrion | 4.750461e-3 |
GO:0030035 | microspike assembly | 4.766408e-3 |
GO:0021502 | neural fold elevation formation | 4.814531e-3 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 4.819984e-3 |
GO:0021554 | optic nerve development | 4.837398e-3 |
GO:0009109 | coenzyme catabolic process | 4.930871e-3 |
GO:0003093 | regulation of glomerular filtration | 4.946495e-3 |
GO:0045932 | negative regulation of muscle contraction | 4.951603e-3 |
GO:0009123 | nucleoside monophosphate metabolic process | 5.028517e-3 |
GO:0051168 | nuclear export | 5.051445e-3 |
GO:0045639 | positive regulation of myeloid cell differentiation | 5.099730e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 5.131220e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 5.131220e-3 |
GO:0016045 | detection of bacterium | 5.165276e-3 |
GO:0007021 | tubulin complex assembly | 5.165276e-3 |
GO:0003018 | vascular process in circulatory system | 5.171070e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 5.190865e-3 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.206112e-3 |
GO:0048710 | regulation of astrocyte differentiation | 5.250028e-3 |
GO:0070232 | regulation of T cell apoptosis | 5.319429e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 5.385180e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.426581e-3 |
GO:0010894 | negative regulation of steroid biosynthetic process | 5.495401e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 5.546546e-3 |
GO:0042541 | hemoglobin biosynthetic process | 5.546546e-3 |
GO:0032781 | positive regulation of ATPase activity | 5.553825e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 5.579363e-3 |
GO:0033363 | secretory granule organization | 5.579363e-3 |
GO:0060996 | dendritic spine development | 5.636339e-3 |
GO:0045920 | negative regulation of exocytosis | 5.652991e-3 |
GO:0009404 | toxin metabolic process | 5.679461e-3 |
GO:0021801 | cerebral cortex radial glia guided migration | 5.708875e-3 |
GO:0070509 | calcium ion import | 5.711190e-3 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.730006e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 5.747394e-3 |
GO:0051725 | protein de-ADP-ribosylation | 5.747394e-3 |
GO:0002071 | glandular epithelial cell maturation | 5.747394e-3 |
GO:0006644 | phospholipid metabolic process | 5.754369e-3 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 5.891082e-3 |
GO:0090257 | regulation of muscle system process | 5.932511e-3 |
GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 5.934495e-3 |
GO:0061360 | optic chiasma development | 5.934495e-3 |
GO:2000597 | positive regulation of optic nerve formation | 5.934495e-3 |
GO:0021633 | optic nerve structural organization | 5.934495e-3 |
GO:0021650 | vestibulocochlear nerve formation | 5.934495e-3 |
GO:0035799 | ureter maturation | 5.934495e-3 |
GO:0010872 | regulation of cholesterol esterification | 5.936024e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 5.953486e-3 |
GO:0007386 | compartment pattern specification | 5.953486e-3 |
GO:0006979 | response to oxidative stress | 6.021585e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 6.022420e-3 |
GO:0009260 | ribonucleotide biosynthetic process | 6.023010e-3 |
GO:0006405 | RNA export from nucleus | 6.091323e-3 |
GO:0045453 | bone resorption | 6.125143e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 6.125317e-3 |
GO:0043304 | regulation of mast cell degranulation | 6.129674e-3 |
GO:0009259 | ribonucleotide metabolic process | 6.161592e-3 |
GO:0046479 | glycosphingolipid catabolic process | 6.185748e-3 |
GO:0090193 | positive regulation of glomerulus development | 6.185748e-3 |
GO:0050710 | negative regulation of cytokine secretion | 6.220436e-3 |
GO:0002444 | myeloid leukocyte mediated immunity | 6.387303e-3 |
GO:0003231 | cardiac ventricle development | 6.416643e-3 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 6.459052e-3 |
GO:2000145 | regulation of cell motility | 6.509883e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 6.629348e-3 |
GO:0034599 | cellular response to oxidative stress | 6.655363e-3 |
GO:0043252 | sodium-independent organic anion transport | 6.675974e-3 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 6.675974e-3 |
GO:0042667 | auditory receptor cell fate specification | 6.675974e-3 |
GO:0016078 | tRNA catabolic process | 6.675974e-3 |
GO:0001682 | tRNA 5'-leader removal | 6.675974e-3 |
GO:0030834 | regulation of actin filament depolymerization | 6.694770e-3 |
GO:0072376 | protein activation cascade | 6.743951e-3 |
GO:0060291 | long-term synaptic potentiation | 6.750521e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 6.752020e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 6.765345e-3 |
GO:0044236 | multicellular organismal metabolic process | 6.851561e-3 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 6.897247e-3 |
GO:0030433 | ER-associated protein catabolic process | 6.923762e-3 |
GO:0072141 | renal interstitial cell development | 6.930540e-3 |
GO:0060084 | synaptic transmission involved in micturition | 6.949331e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 6.949331e-3 |
GO:0071295 | cellular response to vitamin | 6.984433e-3 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 7.015591e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 7.015591e-3 |
GO:0039003 | pronephric field specification | 7.015591e-3 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 7.062045e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 7.106079e-3 |
GO:0048013 | ephrin receptor signaling pathway | 7.136463e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 7.186053e-3 |
GO:0043171 | peptide catabolic process | 7.186053e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 7.250408e-3 |
GO:0010863 | positive regulation of phospholipase C activity | 7.279705e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 7.355163e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 7.366466e-3 |
GO:0007006 | mitochondrial membrane organization | 7.375055e-3 |
GO:0032648 | regulation of interferon-beta production | 7.376097e-3 |
GO:0006706 | steroid catabolic process | 7.394627e-3 |
GO:0032608 | interferon-beta production | 7.437922e-3 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 7.437922e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 7.596659e-3 |
GO:0003219 | cardiac right ventricle formation | 7.596823e-3 |
GO:0006956 | complement activation | 7.607197e-3 |
GO:0060080 | regulation of inhibitory postsynaptic membrane potential | 7.632790e-3 |
GO:0003160 | endocardium morphogenesis | 7.632790e-3 |
GO:0015858 | nucleoside transport | 7.720599e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 7.760465e-3 |
GO:2000210 | positive regulation of anoikis | 7.767124e-3 |
GO:0030325 | adrenal gland development | 7.791330e-3 |
GO:0031329 | regulation of cellular catabolic process | 7.844395e-3 |
GO:0045218 | zonula adherens maintenance | 7.852252e-3 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 7.912589e-3 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 8.142643e-3 |
GO:0051492 | regulation of stress fiber assembly | 8.154591e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 8.241593e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 8.241593e-3 |
GO:0031214 | biomineral tissue development | 8.352121e-3 |
GO:0060214 | endocardium formation | 8.466144e-3 |
GO:0032418 | lysosome localization | 8.630130e-3 |
GO:0019344 | cysteine biosynthetic process | 8.630130e-3 |
GO:0015722 | canalicular bile acid transport | 8.630130e-3 |
GO:0030953 | astral microtubule organization | 8.766994e-3 |
GO:0003218 | cardiac left ventricle formation | 8.766994e-3 |
GO:0061043 | regulation of vascular wound healing | 8.870714e-3 |
GO:0021813 | cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration | 8.870714e-3 |
GO:0000920 | cytokinetic cell separation | 9.037360e-3 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 9.037360e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 9.053697e-3 |
GO:0014015 | positive regulation of gliogenesis | 9.081516e-3 |
GO:0051494 | negative regulation of cytoskeleton organization | 9.307390e-3 |
GO:0042396 | phosphagen biosynthetic process | 9.347035e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 9.347035e-3 |
GO:0014904 | myotube cell development | 9.347035e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 9.347035e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 9.347035e-3 |
GO:0043462 | regulation of ATPase activity | 9.433527e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 9.474288e-3 |
GO:0034629 | cellular protein complex localization | 9.492988e-3 |
GO:0060292 | long term synaptic depression | 9.633473e-3 |
GO:0014014 | negative regulation of gliogenesis | 9.665067e-3 |
GO:0048167 | regulation of synaptic plasticity | 9.667876e-3 |
GO:0010574 | regulation of vascular endothelial growth factor production | 9.688689e-3 |
GO:0050729 | positive regulation of inflammatory response | 9.691399e-3 |
GO:0060017 | parathyroid gland development | 9.845857e-3 |
GO:0032272 | negative regulation of protein polymerization | 9.888179e-3 |
GO:0009912 | auditory receptor cell fate commitment | 9.901359e-3 |
GO:0031333 | negative regulation of protein complex assembly | 9.991884e-3 |
GO:0046931 | pore complex assembly | 1.000281e-2 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1.000281e-2 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 1.000281e-2 |
GO:0045656 | negative regulation of monocyte differentiation | 1.000281e-2 |
GO:0016926 | protein desumoylation | 1.000281e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 1.010844e-2 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 1.015072e-2 |
GO:0006662 | glycerol ether metabolic process | 1.016645e-2 |
GO:0006689 | ganglioside catabolic process | 1.020896e-2 |
GO:0009649 | entrainment of circadian clock | 1.020954e-2 |
GO:0001969 | regulation of activation of membrane attack complex | 1.020954e-2 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.022013e-2 |
GO:0071956 | cellular component maintenance at cellular level | 1.026166e-2 |
GO:0072172 | mesonephric tubule formation | 1.029236e-2 |
GO:0001842 | neural fold formation | 1.031657e-2 |
GO:0042501 | serine phosphorylation of STAT protein | 1.059868e-2 |
GO:0030091 | protein repair | 1.059868e-2 |
GO:0001956 | positive regulation of neurotransmitter secretion | 1.059868e-2 |
GO:0051030 | snRNA transport | 1.064890e-2 |
GO:0010312 | detoxification of zinc ion | 1.064890e-2 |
GO:0005997 | xylulose metabolic process | 1.064890e-2 |
GO:0071260 | cellular response to mechanical stimulus | 1.078891e-2 |
GO:0006821 | chloride transport | 1.084788e-2 |
GO:0043299 | leukocyte degranulation | 1.093240e-2 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 1.099749e-2 |
GO:0033602 | negative regulation of dopamine secretion | 1.113676e-2 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 1.118922e-2 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.118922e-2 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.118922e-2 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.118922e-2 |
GO:0008065 | establishment of blood-nerve barrier | 1.118922e-2 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.118922e-2 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1.118922e-2 |
GO:0060525 | prostate glandular acinus development | 1.129798e-2 |
GO:0072189 | ureter development | 1.131040e-2 |
GO:0030334 | regulation of cell migration | 1.137673e-2 |
GO:0090234 | regulation of kinetochore assembly | 1.144092e-2 |
GO:0009313 | oligosaccharide catabolic process | 1.144092e-2 |
GO:0090169 | regulation of spindle assembly | 1.144092e-2 |
GO:0006518 | peptide metabolic process | 1.182742e-2 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.190708e-2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 1.203434e-2 |
GO:0006750 | glutathione biosynthetic process | 1.223651e-2 |
GO:0010976 | positive regulation of neuron projection development | 1.225308e-2 |
GO:0006959 | humoral immune response | 1.246312e-2 |
GO:0060463 | lung lobe morphogenesis | 1.250681e-2 |
GO:0043243 | positive regulation of protein complex disassembly | 1.250681e-2 |